Literature DB >> 15003795

Metabolic activity of osteoblasts retrieved from osteoarthritic patients after stimulation with mediators involved in periprosthetic loosening.

Patrick Lavigne1, Qin Shi, Daniel Lajeunesse, Faramaze Dehnade, Julio C Fernandes.   

Abstract

OBJECTIVE: To compare the effects of polymethylmetacrylate (PMMA), interleukin-1beta (IL-1beta), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) on osteoarthritic (OA) human osteoblasts (Ob).
METHODS: Ob cell cultures were prepared from metaphyseal trabecular bone of OA patients (n=9). Their cellular metabolic activity was characterized by measuring alkaline phosphatase (ALPase), osteocalcin (Oc), osteoprotegerin (OPG), prostaglandin E2 (PGE2), IL-6, macrophage colony-stimulating factor (M-CSF) and soluble receptor activator of NF-kappaB ligand (sRANKL) in supernatants after Ob stimulation with PMMA, IL-1beta, IL-6 or TNF-alpha.
RESULTS: IL-6 and PGE2 production by Ob was significantly increased by all mediators used. PMMA and TNF-alpha both stimulated M-CSF and sRANKL production whereas PMMA decreased and TNF-alpha augmented OPG release by Ob. The ratio sRANKL/OPG was significantly increased with PMMA and TNF-alpha, and treatment with anti-IL-6 antibodies did not alter this ratio. ALPase levels remained constant while only PMMA affected Oc production. Subclassification of patients into high or low endogenous producers of IL-6 and PGE2 before stimulation of Ob indicated that the two subgroups maintained similar responses to stimulation by all mediators.
CONCLUSION: PMMA and TNF-alpha have comparable dual action on Ob, lowering their anabolic capacity and favoring production of bone resorption activators, an action not mediated by IL-6. This study confirms the important role of PMMA in implant loosening. However, the pertinence of high and low metabolic activities in OA Ob remains unclear, but could be involved in the pathophysiology of bone disease and aseptic loosening.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003795     DOI: 10.1016/j.bone.2003.10.006

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  4 in total

1.  The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.

Authors:  S Kwan Tat; J-P Pelletier; D Lajeunesse; H Fahmi; M Lavigne; J Martel-Pelletier
Journal:  Clin Exp Rheumatol       Date:  2008 Mar-Apr       Impact factor: 4.473

2.  Differential modulation of RANKL isoforms by human osteoarthritic subchondral bone osteoblasts: influence of osteotropic factors.

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Daniel Lajeunesse; Hassan Fahmi; Nicolas Duval; Johanne Martel-Pelletier
Journal:  Bone       Date:  2008-04-26       Impact factor: 4.398

3.  Targeting extracellular signal-regulated kinase (ERK) signaling has therapeutic implications for inflammatory osteolysis.

Authors:  Sung Wook Seo; Daniel Lee; Hiroshi Minematsu; Abraham D Kim; Mike Shin; Samuel K Cho; Dae Won Kim; Jay Yang; Francis Y Lee
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

4.  The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.

Authors:  Kelitha Maxis; Aline Delalandre; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicolas Duval; Daniel Lajeunesse
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.